Whilst discounted playing cards will help ease the stress of significant drug costs while in the temporary, they don't tackle the systemic difficulties driving up prescription price ranges from the U.S. Broader policy changes could deal with the foundation causes of climbing drug rates, like lack of transparency in pricing and the role of intermedi